Related Experiment Video
Updated: Jun 3, 2026

08:12
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
JAK2-positive Philadelphia-negative myeloproliferative neoplasms
Anjali Sharma1, Gurdeep Buxi, Sadhna Marwah
1Department of Pathology, Dr. Ram Manohar Lohia Hospital, PGIMER, New Delhi, India. anjali27sharma@rediffmail.com
Indian Journal of Pathology & Microbiology
|March 12, 2011
Summary
The JAK2 mutation discovery impacts myeloproliferative neoplasms (MPNs) diagnosis and treatment. Clinical, lab, and histology data are crucial for classifying MPNs, even without JAK2 V617F mutations.
Area of Science:
- Hematology
- Oncology
- Molecular Diagnostics
Background:
- The discovery of Janus kinase 2 (JAK2) mutations has significantly influenced the understanding and management of BCR/ABL-negative myeloproliferative neoplasms (MPNs).
- Accurate diagnosis and subclassification of MPNs remain critical for effective treatment strategies.
- While JAK2 mutations are key, other diagnostic parameters are essential for comprehensive evaluation.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
